GraniteShares 3x Short AstraZeneca Daily ETC
ETFs & Funds · GBX · LSE
Price
p651.88
Cap
—
Earnings
—
30d Trend
+9.9%
Near 52-week lows — potential value or falling knife
69% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 24×Macro 0.99 (−1%)=24
RISK LEVEL
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 61 (Greed) - Data: 60%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate GraniteShares 3x Short AstraZeneca Daily ETC at 24/100 — a VERY WEAK reading on the Brain47 Signal. The strongest factor is quality at 50/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
+5.9%
3 MONTHS
+16.0%
12 MONTHS
—
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Limited short-term thesis. Quality (50) and Fundamentals (50) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 69%. I classify this as a speculative position — elevated volatility at 69% and asymmetric payoff potential define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.